Corcept Therapeutics
CORT
#2462
Rank
C$9.98 B
Marketcap
C$91.22
Share price
-2.09%
Change (1 day)
-14.63%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of November 2026 (TTM): 7.30

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.97. At the end of 2026 the company had a P/S ratio of 13.0.

P/S ratio history for Corcept Therapeutics from 2007 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202613.0146.63%
20255.29-35.09%
20248.1417.34%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59-9.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.00-31.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.47-66.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9 90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.93-32.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.42-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
3.21-56.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-73.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.22-55.94%๐Ÿ‡บ๐Ÿ‡ธ USA